arrow
W

Wendy Y. Cheng

heor, analysis group, inc., boston, ma, usa
H指数:23
被引数:1,692

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study

真性红细胞增多症高风险患者在接受一线治疗效果不佳后切换至鲁索利替尼治疗与非切换者的临床结局比较:PV-Switch研究的结果

2025-07-040
OA
Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli-Caused Uncomplicated Urinary Tract Infection
2024-04-040
OAAI
Dr Singer et al reply
2023-12-010
OA